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Calotropis procera Linn., also known as Alarka, Surya,
Suuryaahvya, Vikirna, Vasuka, Tapana, Tuulaphala, Kshirpar-
na, Arkaparna, Aasphota Aakh, Madaar, Ashar in India
(Khare, 2007), belongs to the Asclepiadaceae family and grows
in tropical region and most abundant in Bangladesh, India,
Burma, Pakistan and in the subHimalayan tract (CSIR,
1992; Kritikar and Basu, 1999). This plant was used ﬁrst time
as a medicinal plant by Ved Sushruta, which is about 800–900
AD. C. procera is used from very ancient period in folk beliefs
as well as a drug of choice for different ailments. Its different
formulas are found in old Vedic book of India, ‘‘Sushruta
Samhita’’. In the old days, Hindus used it at the time of wor-
ship of sun in the period of Ved. Therefore, the name of‘‘Arkaputra’’ or ‘‘Arka prana’’ was awarded to this plant,
which means such leaf or shining leaf.
Different parts of the plant have been used in Indian
traditional system of medicine for the treatment of leprosy,
ulcers, tumors, piles and diseases of spleen, liver and abdomen
(Kritikar and Basu, 1999).
The water, ethanol, acetone and some other organic solvent
extracts of this plant possess insecticidal (Moursy, 1997), larvi-
cidal (Markouk et al., 2000), anti-bacterial and anti-parasitic
(Larhsini et al., 1999) activities.
The milky white latex obtained from the plant exhibits po-
tent anti-inﬂammatory activity in various animal models that
is comparable to standard anti-inﬂammatory drugs (Sangraula
et al., 2002). The latex of C. procera has also been tested in
guinea pigs and found to have a good efﬁcacy in healing of
dermal wounds (Rasik et al., 1999). The aqueous extract of
the latex has been shown to inhibit cellular inﬁltration and af-
ford protection against development of neoplastic changes in
the transgenic mouse model of hepatocellular carcinoma
(Choedon et al., 2006). The chloroform extract of the root
has been shown to exhibit protective activity against carbon
tetrachloride induced liver damage (Basu et al., 1992). An
ethanol extract of the ﬂower is reported to have anti-microbial,
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1988), anticancerous (Smit et al., 1995) and antimalarial (Shar-
ma and Sharma, 1999) activities.
The different parts of the plant have been investigated by
several workers and found to contain pentacyclic triterpenes
(Ansari and Ali, 1999, 2000; Gupta et al., 2003; Khan et al.,
1988), alkaloid (Israili and Israr, 1978), cardinolides (Seiber
et al., 1982), phytosterols (Khan and Malik, 1989; Lal et al.,
1985) and triterpenoid saponins (Gupta et al., 2000).
2. Experimental
2.1. Plant collection
Fresh or dried plant material can be used as a source for the
extraction of secondary plant components. Freshly harvested
and dried material is more commonly used since old dried
material stored for a long period may undergo some qualita-
tive changes. Latex of C. Procera was collected from the rural
areas of Rewa and Bhopal districts in different month of 2009.
These plants were identiﬁed by the Botany Department of
Bareily College, Bareily. The pooled frozen latex was thawed
a fortnight after collection when the serum separated and the
solid part of the latex could easily be removed and dried be-
tween ﬁlter paper sheets.
2.2. Extraction
The dried latex of plant (5 kg) was soaked in with ethanol at
room temperature for two weeks. The ﬁltrate was evaporated
under reduced pressure to obtain a dark brown gunmy material
(750 g), partitioned between n-hexane, chloroform, acetone,
ethyl acetate and n-butanol, yielding petrol–ether soluble
(80 g), chloroform soluble (285 g), ethyl acetate soluble (112 g)
and n-butanol soluble (159 g) fractions. The petrol–ether solu-
ble fractionwas evaporated under vacuumon rotatory evapora-
tor below 50 C temperature to yield 60 gm of petrol–ether
extract. A well-stirred suspension of silica gel (100–150 g in pet-
rol–ether 60–80 C) was poured into column (150 cm long and
50 mm in diameter). When the absorbent was well settled, the
excess of petrol–ether was allowed to pass through column.
Slurry was made to petrol–ether extract with 5 g of silica gel in
petrol–ether and was digested to well settle column. The column
was successively eluted with the solvents and solventmixtures of
increasing polarity. Elution with chloroform/ethyl acetate (3:5)
yielded compound CP-1. Whereas on elution with ethyl ace-
tone/acetate (1:1) afforded compound CP-2. Elution with chlo-
roform/EtOAc (3:2) provided compound CP-3. Similarly the
acetone soluble fraction was also subjected to column chroma-
tography. The column was successively eluted with the solvents
and their mixtures of increasing polarity. Elution with petrol/
acetone (8:2) yielded compoundCP-4. The ethyl acetate soluble
thus obtained was successively eluted with the solvents and their
mixtures of increasing polarity. Elution with benzene/ethyl ace-
tate (8:2) afforded CP-5 (Table 1).
2.3. Compound CP-1
White powder; m.p.: 198–201 C; IR (CHCl3) kmax: 1720, 1320,
1635 and 885 cm1 Mass spectra m/z: 468 [M]+, 453
[MMe]+, 408 [MAcOH]+, 393 [MMeAcOH]+, 272
[MC12H20O2]+, 257 [MC13H23O2]+, 249 [MC16H27]+,218 [MC16H25O2]+, 189 [MC16H27AcOH]+; 1H NMR
(300 MHz, CDCl3): d 4.52 (1H, dd, Jax,ax = 9.8, Jax,eq =
4.5 Hz, H-3), 2.12 (3H, s, O–C–Me), 1.04 (3H, s, 27-Me)
1.02 (3H, s, 26-Me), 1.01 (3H, s, 23-Me), 0.91 (3H, d,
J= 6.6 Hz 30-Me), 0.83(3H, s, 25-Me), 0.82 (6H, s, 24,28-
Me), 4.67–4.62 (2H, br s H-29).
2.4. Compound CP-2
Colorless needles; Rf (silica gel): 0.38 (MeOH–CH2Cl2) 1:9; MS
m/z (rel. int.%): 414 (76), 412 (92), 396 (22), 369 (17), 351 (14),
329 (10), 300 (43), 283 (10), 271 (43), 255 (47), 231 (18), 213
(22), 69 (87), 51 (100); 1H NMR (CDCl3): d 5.01 (1H, dd,
J= 8.4, 15.2 Hz, H-23), 5.15 (1H, dd, J= 8.4, 15.2 Hz,
H-22), 5.35 (2H, d, J= 5.2 Hz, H-6), 3.51 (2H, m, H-3), 1.00
(3H, s, 19-Me), 0.69 (3H, s, 18-Me), 1.03 (3H, d, J= 6.60 Hz,
21-Me), 0.85 (3H, d, J= 6.60 26-Me), 0.81 (3H, d,
J= 7.53 Hz, 29-Me), 0.80 (3H, d, J= 6.41 Hz, 27-Me).
2.5. Compound CP-3
White crystals; m.p.: 189–191 C; IR (CHCl3) kmax: 3510
(hydroxyl group), 3045, 1640, 811 (tri substituted double
bond) cm1; MS m/z (rel. int.%): 426 [M+H]+, (10), 411
[C30H50OCH3]+ (15), 408 [C30H50OH2O]+ (25), 393
[C30H50OCH3H2O]+ (30), 273 [a]+ (42), 259 [b]+ (35),
247 [c (R.D. fragment)]+ (42), 220 [d]+ (50), 205 [e]+ (100).
2.6. Compound CP-4
Colorless shining needles; m.p.: 167–168 C; IR mmax (CHC13):
3420, 3075, 1645, 890 cm1; MS m/z (rel. int.%): 426 (30)
[M]+, 411 (10) [MMe]+, 408 (16) [MH20]+, 393 (8)
[MMeH20]+, 272 (10) [ion d]+, 257 (20) [ion c]+, l218
(6) [ion b]+, 207 (100) [ion a]+, 189 (62) [ion aH20]+.
2.7. Compound CP-5
Colorless crystals; m.p.:165–166 C; IR mmax: 3400 (OH), 2980
(CH), 1760 (five-membered lactone ring) and 1570 (C‚C) cm1;
MS m/z (rel. int.%): 470 [M+H]+ (29), 452 [MH20]+ (I2.0),
263 [C16H23O3; fragment a] (23.6), 249 [C15H21O3; fragment b]
(8.8), 235 [C16H23O; (fragment a)CO] (18.5), 220 [C151124O;
(fragment a)CO2+H] (13.3), 207 [C14H23O; fragment c]
(19.5), 205 [C14H21O; (fragment b)CO2] (22.0), 189 [C14H21;
(fragment c)H2O] (33.4) and 187 [C14H19; (fragment
b)CO2H2O] (12.6); 1H NMR (CDC13, 300 MHz) 3.18 (H-3,
1H,dd, J= 11.4, 4.8 Hz), 3.55–3.73 (each 1H, d, J= 11.0 Hz,
H-27a, 27b), 1.05 (3H, d, J= 7.1 Hz, H-30), 0.99 (3H, s, 23-
Me), 0.97 (3H, s, 24-Me), 0.94 (3H, s, 25-Me), 0.88 (3H, s, 29-
Me).3. Results and discussion
3.1. Compound CP-1
Compound CP-1 was isolated as white needle, m.p.: 198–
201 C, on elution with chloroform/ethyl acetate (3:5). Mass
spectrum showed [M] + ion at m/z 468 corresponding to
molecular formula C32H52O2. In the
1H NMR of CP-1 a pair
of broad singlets observed at d 4.67 and 4.62 was indicative of
Table 1
Assignment/(dC, ppm) CP-1 CP-2 CP-3 CP-4 CP-5
C-1 38.51 37.3 38.50 38.49 37.7
C-2 23.73 31.7 27.09 27.00 27.3
C-3 81.89 71.8 77.87 79.05 78.9
C-4 37.86 42.2 37.81 38.80 32.8
C-5 55.50 140.8 55.91 55.47 55.2
C-6 18.27 121.7 33.71 18.42 18.2
C-7 34.09 31.9 122.78 33.95 33.1
C-8 41.00 31.9 141.72 154.37 38.1
C-9 89.78 50.2 56.09 39.40 47.6
C-10 37.55 36.5 38.07 30.99 36.4
C-11 21.55 21.1 35.72 37.85 23.8
C-12 25.67 39.7, 39.8 23.70 25.55 28.1
C-13 39.29 42.3 32.20 39.26 88.1
C-14 42.10 56.8, 56.9 34.92 42.20 46.8
C-15 26.21 24.3, 24.4 43.12 25.95 26.7
C-16 28.69 28.2, 28.9 52.42 28.01 25.7
C-17 37.57 55.9, 56.1 18.21 18.42 48.2
C-18 59.42 11.8, 12.0 29.86 33.95 136.7
C-19 154.56 19.4 37.20 40.95 24.8
C-20 39.43 36.1, 40.5 18.30 48.76 37.1
C-21 31.21 18.9, 21.1 35.01 30.99 30.7
C-22 38.98 33.9, 138.3 12.92 37.85 31.4
C-23 28.00 26.1, 129.3 140.97 28.00 28.1
C-24 16.55 45.8, 51.2 37.10 16.38 15.5
C-25 15.98 29.2, 31.9 21.61 15.69 16.1
C-26 16.35 19.8, 21.2 21.60 16.73 17.1
C-27 25.55 19.0 13.50 24.94 62.5
C-28 28.11 23.1, 25.4 19.36 28.01 178.9
C-29 107.25 12.2 25.59 107.72 19.5
C-30 19.55 14.09 19.00 20.7
CH3–C–O– 170.85
CH3–C–O– 21.23
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on the basis of biogenetic consideration. Furthermore a two
proton double doublet observed at d 4.52 (1H, s, J= 9.8,
4.5 Hz, H-3) was attributed to the proton attached to the car-
bon bonded to the acetoxy group, showing a- and axial conﬁg-
uration, thus conﬁrming that acetoxy group must be b- and
equatorial at the usual C-3 position (Alam and Ali, 2009).
The 1H NMR of CP-1 revealed signals for six singlet
methyl at d 1.04 (s, H-27), 1.01 (s, H-23), 1.02 (s, H-26), 0.83
(s, H-25) and 0.82 (s, H-24 and H-28), a doublet methyl at d
0.91 (d, J= 6.6 Hz, H-30), A signal observed at d 1.12 assign-
able to the methyl attached to the acetoxy group. The 13C
NMR spectrum of this compound showed 32 signals clearly
indicating that the compound contains eight methyl, eleven
methylene, six methine groups and seven quaternary carbons.
On the basis of these spectral data, the compound CP-1 was
identiﬁed as urs-19(29)-en-3-yl acetate. All these spectral data
were in good concurrence with those reported in the literature
for calotropenyl acetate (Ali, 2001).
3.2. Compound CP-2
Compound CP-2 was isolated as colorless needles, on elution
with ethyl acetone/acetate (1:1). This compound gave purple
coloration upon spraying with anisaldehyde reagent. The
sample showed a dark green colour with Liebermann–Burchard reagent, which is typical of a steroid. In the 1H
NMR spectrum, the signal at d 5.01 (1H, dd, J= 8.4,
15.2 Hz), 5.15 (1H, dd, J= 8.4, 15.2 Hz) and 5.35 (2H, d,
J= 5.2 Hz) could be assigned to H-23 and H-22 of stigmas-
terol and H-6 of b-sitosterol and stigmasterol, respectively.
The integration value for H-6 was twice those of H-22 or H-
23. Therefore, it could be deduced that the compound was a
1:1 mixture of b-sitosterol and stigmasterol. The 13C NMR
spectrum of this compound displayed 43 signals.
The compound CP-2 in its EI-MS showed two major
molecular ion peaks at m/z 412 and 414. The fragmentation
pattern with signiﬁcant peaks at m/z 396, 369, 351, 329, 300,
273, 271, 231 and 213 was reminiscent of a sterol mixture of
stigmasterol and b-sitosterol. The NMR data of this com-
pound were in full agreement with the published valued mix-
ture of b-sitosterol and stigmasterol (Wright et al., 1978).
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The compound was isolated as white crystals, m.p.: 189–
191 C, by eluting the column with chloroform/EtOAc (3:2).
The molecular ion peak of this compound in mass spectra
m/z at 426 corresponds to the molecular formula C30H50O.
The IR spectrum of the compound showed absorption bands
at 3450 (hydroxyl group) and 3045, 1640, 811 (trisubstituted
double bond). The mass spectrum of this compound showed
characteristic peaks of bauerene and multiﬂorene type triter-
penes having double bond at 7(8) (Budzikiewicz et al., 1963).
An eminent fragment ion at m/z 247 arises by retro Diels Alder
decomposition of ring; ‘c’ proceeding the initial rearrangement
of C-9 proton (Budzikiewicz et al., 1963). The 1H NMR spec-
trum provided signals at d 0.85 (3H), 0.93 (3H), 0.97 (6H), 0.95
(3H), 1.05 (3H), 1.07 (3H) and 1.02 (3H) were assignable for
eight tertiary methyl groups. In the 1H NMR a pair of dou-
blets at d 3.21(Jax,ax = 9.7 Hz, Jax,eq = 4.2 Hz) were assigned
to a-axial proton germinal to hydroxyl group, one proton dou-
blet observed at d 5.47 (d, J= 8.9, 4.1 Hz) assignable for ole-
ﬁnic proton. The 13C NMR spectrum exhibited 30 carbon
signals for different type carbon atoms. Survey of the literature
showed that this compound is similar to multiﬂorenol (Bhan-
dari and Rastogi, 1984).
3.4. Compound CP-4
The compound was isolated, from acetone extract by eluting
column with petrol/acetone (8:2). In its electro spray mass
spectrum the molecular ion peak of the compound at m/z
426 [M+H]+ corresponded to the molecular formula
C30H50O. This compound responded to Liebermann–Bur-
chard test and showed violet coloration with ceric sulphate,
suggesting its triterpenic nature. The IR spectrum showed
absorption bands at 3420, 3075, 1645 and 890 cm1 assignable
for the hydroxyl and a methylene groups, respectively.
The 1H NMR spectrum showed signals for vinylic proton
at d 4.65–4.70 (2H, br s) and a proton geminal to the hydroxyl
group at d 3.23. In addition there were signals at d 0.93 (3H, d,
J= 6.2 Hz) allocated to one secondary and at d1.05 (3H), 1.02
(3H), 0.99 (3H), 0.84 (3H) and 0.82 (6H) six tertiary methyl
groups (Rahman, 1986). The mass spectrum of this compound
was characteristic of pentacyclic triterpene of the ursane series
with saturation in rings A, B, C and D. The major ions ‘a’ and
‘b’ were generated by the transfer of hydrogen from C-26 to C-
11 accompanied by cleavage of 9–11 and 8–14 bonds with
charge retention on either of the resulting fragments (Benn
and Gunther, 1983; Karline and Djerassi, 1966; Barton and
de Mayo, 1954). Oxidation of CP-4 with Jones reagent gave
calotropenone (CP-4a). The latter gave positive Zimmermann
test indicating the presence of 3-oxo group (Panosyan et al.,
1977). The NaBH4 reduction of CP-4a regenerated the parent
alcohol CP-4, conﬁrming the equatorial orientation of the hy-
droxyl group in CP-4. The conﬁguration of the hydroxyl
group in CP-4 was also indicated by the characteristic down-
ﬁeld shift of the 3-a-H which appeared as double doublets at
J ax,ax = 9.8 Hz and J ax,eq = 4.7 Hz owing to coupling with
proton at C-2. The catalytic reduction of CP-4 afforded the
corresponding dihydro derivative calotropanol (CP-4b) which
was identiﬁed as 3-hydroxy ursane through comparison of
spectral data with these reported in the literature (Domingelez
et al., 1974; Hassall and Reyle, 1959). Its 1H NMR spectrumshowed the absence of oleﬁnic proton but gave a signal at d
0.86 (3H, d, J= 6.9 Hz) assignable for an additional second-
ary methyl group. The reduction of the methylene group was
expected to form a methyl group with a- or b-orientation.
However, the former was formed in trace amount due to steric
crowding of the b-oriented methyl group at C-8. These obser-
vations left only one position for the vinylic double bond, i.e.,
C-19 (Khan et al., 1988). In the 13C NMR spectrum the signals
of C-3, C-12, C-13, C-21, C-29 and C-30 could easily be corre-
lated with the corresponding protons in the 1H NMR spec-
trum. The 13C NMR spectrum of the compound showed
signals for 23 carbons atoms, which revealed the presence of
seven methyl, 11 methylene and six methine carbon atoms.
On the basis of these spectral data the compound was identi-
ﬁed as urs-19(29)-en-3-b-ol. Its acetate was been isolated from
the same plant source reported in literature (Kojima and
Ogura, 1989).
3.5. Compound CP-5
The compound (m.p.: 165–166 C) was isolated from ethyl ace-
tate soluble fraction by eluting the column with benzene/ethyl
acetate (8:2). The mass spectrum exhibited a molecular ion
peak at m/z 470 which consistent with the molecular formula
C30H46O4. The IR absorption at 1760 cm
1 and a carbon sig-
nal at dC 178.9 suggested the presence of a lactone moiety. The
IR spectrum showed absorptions at 1760 cm1 suggesting the
presence of a ﬁve membered lactone ring and a band at
1620 cm1 for C‚C. The molecular formula showed eight
double bond equivalents, ﬁve of which were accounted for
by the pentacyclic ring nucleus, two by the lactone ring and
one by a C‚C. These features suggested that the remaining
two oxygen atoms are present as hydroxyl groups
(3400 cm1). The NMR spectrum showed a double doublet
at d 3.18 (J= 11.4 and 4.8 Hz) and dC 78.9 attributable to
the proton germinal to the hydroxyl group placed at C-3 on
biogenetic consideration (Jacobs and Hoffman, 1928). The
coupling constants and the chemical shifts of H-3 favored
the b-orientation (equatorial) of the hydroxyl group at C-3
(Siddiqui et al., 1990). The 1H NMR spectrum further showed
two AB doublets at d 3.73 and 3.55 each with a geminal cou-
pling of 11.0 Hz (dC 62.5), indicating a methylene carbon
linked to an oxygen function. Further, in the 1H NMR spec-
trum six methyl signals were observed, ﬁve as singlets at d
0.78, 0.94, 0.97, 0.99 and 1.88 and one as a doublet at d 1.05
(J= 7.1 Hz). These data pointed out that compound CP-5 be-
longs to the ursane series of triterpcnes, with two methyls func-
tionalized, one involved in the lactone ring and the other
forming a –CH2OH function. The chemical shift of one of
the methyls (d 1.88) indicated that it is vinylic and presence
of only one methyl as a doublet (d 1.05) along with absence
of any vinylic proton led to place a double bond at C-18 (dC
136.7). In mass spectra the fragments a–c exempliﬁed that
the lactone ring and the remaining hydroxyl group are present
in rings C and D. The 13C NMR spectrum also favors the pres-
ence of lactone ring between C-13 and C-28 and the hydroxyl
group at C-27. Thus on the basis of the above spectral evi-
dences, the structure of the isolated compound CP-5 was ﬁnal-
ly concluded to be 3b,27-dihydroxy-urs-18-en-13,28-olide,
good concurrence with those reported in the literature (Kang,
1987; Numata et al., 1990; Siddiqui et al., 1992; Begum et al.,
1993).
S234 S.J. Chundattu et al.4. Conclusion
We believe this is the ﬁrst report describing the isolation of
3b,27-dihydroxy-urs-18-en-13,28-olide from C. procera.
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